Medical devices, healthcare technology and the business of care
510(k) clearance · K252814

Profoject Low Dead Space Syringe /Profoject Tuberculin Syringe; Profoject Low Dead Space Syringe with Needle /Profoject Tuberculin Syringe with Needle; Profoject Low Dead Space Syringe with Permanent Needle /Profoject Tuberculin Syringe with Permanent Needle; Profoject Low Dead Space Safety Syringe /Profoject Tuberculin Safety Syringe

CMT Health PTE., Ltd. · Decision date Feb 19, 2026

FDA DECISIONK252814

What did the FDA decide?

FDA records K252814 as a 510(k) premarket notification, with a decision dated Feb 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Feb 19, 2026

FDA source record

Regulatory record facts

Identifier
K252814
Regulatory pathway
510(k) premarket notification
Product code
QNQ
Decision code
SESE
Decision date
Feb 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Low Dead Space Piston Syringe.

Product code
QNQ
FDA device class
2

FDA decision timeline

  1. K252814 received

    Application receipt date recorded by FDA.

  2. K252814 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

CMT Health PTE., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Singapore

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records